Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cochrane

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Oncogene|June 6, 2017
The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancerA Szczepny, S Rogers, W S N Jayasekara, et al.
Plos One|June 18, 2019
Designer Sinorhizobium meliloti strains and multi-functional vectors enable direct inter-kingdom DNA transferStephanie L Brumwell, Michael R MacLeod, Tony Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 8, 2025
Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signaturesEvan Gibbard, Dawn R Cochrane, Ramlogan Sowamber, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Science Translational Medicine|March 12, 2025
A humanized antibody against mucormycosis targets angioinvasion and augments the host immune responseYiyou Gu, Shakti Singh, Abdullah Alqarihi, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial CancersAmy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, et al.
Science (New York, N.Y.)|February 7, 1986
Oregon subduction zone: venting, fauna, and carbonatesL D Kulm, E Suess, J C Moore, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Human Pathology|October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkersEvan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Oncogene|June 6, 2017
The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancerA Szczepny, S Rogers, W S N Jayasekara, et al.
Plos One|June 18, 2019
Designer Sinorhizobium meliloti strains and multi-functional vectors enable direct inter-kingdom DNA transferStephanie L Brumwell, Michael R MacLeod, Tony Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 8, 2025
Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signaturesEvan Gibbard, Dawn R Cochrane, Ramlogan Sowamber, et al.
Plos One|September 12, 2013
Type-specific cell line models for type-specific ovarian cancer researchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Science Translational Medicine|March 12, 2025
A humanized antibody against mucormycosis targets angioinvasion and augments the host immune responseYiyou Gu, Shakti Singh, Abdullah Alqarihi, et al.
Plos One|October 12, 2013
Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchMichael S Anglesio, Kimberly C Wiegand, Nataliya Melnyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial CancersAmy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, et al.
Science (New York, N.Y.)|February 7, 1986
Oregon subduction zone: venting, fauna, and carbonatesL D Kulm, E Suess, J C Moore, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Human Pathology|October 30, 2020
Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkersEvan Gibbard, Dawn R Cochrane, Jennifer Pors, et al.
Pageof 18